Riluzole stimulates BDNF release from human platelets
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/225834 |
Resumo: | Brain-derived neurotrophic factor (BDNF) has several functions in the central nervous system, where it contributes to brain development and its functionality through affecting neuronal survival and activity and also modulating neurotransmitter levels. This neurotrophin is also found in the serum, but its origin and peripheral function remain unknown. Although the source of circulating BDNF is uncertain, it is stored in platelets and can be released through pharmacological treatment. Decreased levels of BDNF in the serum have been related to the pathophysiology of depression, and this relationship is reinforced by the reversal of this condition by treatment with antidepressants. Recently, riluzole has been proposed for the treatment of depression because it has the ability to lower extracellular glutamate levels and increase BDNF expression; and both mechanisms could be associated with its antidepressant action. Considering that riluzole enhances BDNF levels in the serum of patients, we investigated if treatment with this drug could stimulate the release of this neurotrophin from human platelets obtained from healthy subjects. When platelets were incubated with riluzole for 4 h, the basal value of BDNF (92.9 ± 11.1 pg 10−6 platelets) was significantly increased ( < 0.05, = 27). This stimulatory effect was achieved at low concentrations of riluzole (from 10 M) and was not observed when platelets were incubated with the drug for 24 h. The direct action of riluzole evoking BDNF release from human platelets at therapeutic concentrations is important and may contribute to the understanding of its mechanisms of action in the treatment of depression. |
id |
UFRGS-2_ddeb17d9a880bcf34d1bbdeb48e23908 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/225834 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Turck, PatrickFrizzo, Marcos Emilio dos Santos2021-08-18T04:39:24Z20152314-6133http://hdl.handle.net/10183/225834000968009Brain-derived neurotrophic factor (BDNF) has several functions in the central nervous system, where it contributes to brain development and its functionality through affecting neuronal survival and activity and also modulating neurotransmitter levels. This neurotrophin is also found in the serum, but its origin and peripheral function remain unknown. Although the source of circulating BDNF is uncertain, it is stored in platelets and can be released through pharmacological treatment. Decreased levels of BDNF in the serum have been related to the pathophysiology of depression, and this relationship is reinforced by the reversal of this condition by treatment with antidepressants. Recently, riluzole has been proposed for the treatment of depression because it has the ability to lower extracellular glutamate levels and increase BDNF expression; and both mechanisms could be associated with its antidepressant action. Considering that riluzole enhances BDNF levels in the serum of patients, we investigated if treatment with this drug could stimulate the release of this neurotrophin from human platelets obtained from healthy subjects. When platelets were incubated with riluzole for 4 h, the basal value of BDNF (92.9 ± 11.1 pg 10−6 platelets) was significantly increased ( < 0.05, = 27). This stimulatory effect was achieved at low concentrations of riluzole (from 10 M) and was not observed when platelets were incubated with the drug for 24 h. The direct action of riluzole evoking BDNF release from human platelets at therapeutic concentrations is important and may contribute to the understanding of its mechanisms of action in the treatment of depression.application/pdfengBioMed Research International. New York. Vol. 2015 (2015), 6p., ID 189307Fator neurotrófico derivado do encéfaloRiluzolPlaquetasDepressãoRiluzole stimulates BDNF release from human plateletsEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT000968009.pdf.txt000968009.pdf.txtExtracted Texttext/plain33035http://www.lume.ufrgs.br/bitstream/10183/225834/2/000968009.pdf.txt4043e129ffd22503761be6c6e6b2c181MD52ORIGINAL000968009.pdfTexto completo (inglês)application/pdf1202405http://www.lume.ufrgs.br/bitstream/10183/225834/1/000968009.pdf075471a73bd478bd5b2810d8b2a444cbMD5110183/2258342021-08-18 05:20:18.273oai:www.lume.ufrgs.br:10183/225834Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2021-08-18T08:20:18Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Riluzole stimulates BDNF release from human platelets |
title |
Riluzole stimulates BDNF release from human platelets |
spellingShingle |
Riluzole stimulates BDNF release from human platelets Turck, Patrick Fator neurotrófico derivado do encéfalo Riluzol Plaquetas Depressão |
title_short |
Riluzole stimulates BDNF release from human platelets |
title_full |
Riluzole stimulates BDNF release from human platelets |
title_fullStr |
Riluzole stimulates BDNF release from human platelets |
title_full_unstemmed |
Riluzole stimulates BDNF release from human platelets |
title_sort |
Riluzole stimulates BDNF release from human platelets |
author |
Turck, Patrick |
author_facet |
Turck, Patrick Frizzo, Marcos Emilio dos Santos |
author_role |
author |
author2 |
Frizzo, Marcos Emilio dos Santos |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Turck, Patrick Frizzo, Marcos Emilio dos Santos |
dc.subject.por.fl_str_mv |
Fator neurotrófico derivado do encéfalo Riluzol Plaquetas Depressão |
topic |
Fator neurotrófico derivado do encéfalo Riluzol Plaquetas Depressão |
description |
Brain-derived neurotrophic factor (BDNF) has several functions in the central nervous system, where it contributes to brain development and its functionality through affecting neuronal survival and activity and also modulating neurotransmitter levels. This neurotrophin is also found in the serum, but its origin and peripheral function remain unknown. Although the source of circulating BDNF is uncertain, it is stored in platelets and can be released through pharmacological treatment. Decreased levels of BDNF in the serum have been related to the pathophysiology of depression, and this relationship is reinforced by the reversal of this condition by treatment with antidepressants. Recently, riluzole has been proposed for the treatment of depression because it has the ability to lower extracellular glutamate levels and increase BDNF expression; and both mechanisms could be associated with its antidepressant action. Considering that riluzole enhances BDNF levels in the serum of patients, we investigated if treatment with this drug could stimulate the release of this neurotrophin from human platelets obtained from healthy subjects. When platelets were incubated with riluzole for 4 h, the basal value of BDNF (92.9 ± 11.1 pg 10−6 platelets) was significantly increased ( < 0.05, = 27). This stimulatory effect was achieved at low concentrations of riluzole (from 10 M) and was not observed when platelets were incubated with the drug for 24 h. The direct action of riluzole evoking BDNF release from human platelets at therapeutic concentrations is important and may contribute to the understanding of its mechanisms of action in the treatment of depression. |
publishDate |
2015 |
dc.date.issued.fl_str_mv |
2015 |
dc.date.accessioned.fl_str_mv |
2021-08-18T04:39:24Z |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/225834 |
dc.identifier.issn.pt_BR.fl_str_mv |
2314-6133 |
dc.identifier.nrb.pt_BR.fl_str_mv |
000968009 |
identifier_str_mv |
2314-6133 000968009 |
url |
http://hdl.handle.net/10183/225834 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
BioMed Research International. New York. Vol. 2015 (2015), 6p., ID 189307 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/225834/2/000968009.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/225834/1/000968009.pdf |
bitstream.checksum.fl_str_mv |
4043e129ffd22503761be6c6e6b2c181 075471a73bd478bd5b2810d8b2a444cb |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447762792087552 |